Related Experiment Videos
Myasthenic Crisis.
Jawad F. Kirmani1, Abutaher M. Yahia, Adnan I. Qureshi
1Departments of Neurosurgery and Neurology, State University of New York at Buffalo, School of Medicine and Biomedical Sciences, 3 Gates Circle, Buffalo, NY 14209, USA. jkirmani@hotmail.com
Current Treatment Options in Neurology
|December 11, 2003
Summary
Myasthenia gravis crisis, a severe complication, requires early mechanical ventilation for better outcomes. Plasma exchange shows greater efficacy than intravenous immunoglobulin for respiratory failure in these patients.
Area of Science:
- Neurology
- Critical Care Medicine
Background:
- Myasthenia gravis is a common neuromuscular junction disorder.
- Myasthenia crisis, characterized by respiratory failure, affects 15-20% of patients and is life-threatening.
Purpose of the Study:
- To review the management of myasthenia gravis crisis.
- To highlight the importance of early mechanical ventilation.
- To compare treatment efficacies for respiratory failure.
Main Methods:
- Review of current literature and clinical recommendations.
- Emphasis on early intubation and mechanical ventilation strategies.
- Discussion of therapeutic options including plasma exchange and immunotherapies.
Main Results:
- Early intubation and mechanical ventilation are crucial for managing myasthenia gravis crisis.
- Plasma exchange appears more effective than intravenous immunoglobulin for respiratory failure.
- The role of immunosuppression and pyridostigmine in the acute setting is limited and debated.
Conclusions:
- Liberal and early intubation is recommended for myasthenia gravis crisis.
- Plasma exchange efficacy needs confirmation via randomized trials.
- Individualized treatment approaches are essential for optimal patient care.